These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20447062)

  • 1. Feasibility of using cryopreserved lymphoblastoid cells to diagnose some lysosomal storage diseases.
    de Mello AS; Provin F; Michelin-Tireli K; Camelier MV; Coelho JC
    Cell Prolif; 2010 Apr; 43(2):164-9. PubMed ID: 20447062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-induced transformation of B cells for the diagnosis of genetic metabolic disorders--enumerative conditions for cryopreservation.
    Mello AS; Burin MG; Michellin K; Viapiana M; Giugliani R; Coelho JC; Bauer ME
    Cell Prolif; 2006 Feb; 39(1):29-36. PubMed ID: 16426420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of one year of cryopreservation on the activity of lysosomal hydrolases from EBV-transformed lymphocytes.
    de Mello AS; Mendes FB; Michelin-Tireli K; Camelier MV; Coelho JC
    J Biomed Biotechnol; 2011; 2011():132581. PubMed ID: 21660133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference values for lysosomal enzymes activities using dried blood spots samples - a Brazilian experience.
    Müller KB; Rodrigues MD; Pereira VG; Martins AM; D'Almeida V
    Diagn Pathol; 2010 Sep; 5():65. PubMed ID: 20920262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cut-off values of neonatal lysosomal storage disease-related enzymes detected by tandem mass spectrometry.
    Li G; Tian L; Guo Y; Li Y; Sun M; Zou H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 51(3):321-325. PubMed ID: 35462462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LAMP2 as a marker of EBV-mediated B lymphocyte transformation in the study of lysosomal storage diseases.
    Mello AS; Goldim MP; Mezzalira J; Garcia CS; Daitx VV; Castilhos CD; Viegas MS; Vieira OV; Coelho JC
    Mol Cell Biochem; 2014 Jan; 385(1-2):1-6. PubMed ID: 24068328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal acid hydrolases in established lymphoblastoid cell lines, transformed by Epstein-Barr virus, from patients with genetic lysosomal storage diseases.
    Minami R; Watanabe Y; Kudoh T; Suzuki M; Oyanagi K; Orii T; Nakao T
    Hum Genet; 1978 Oct; 44(1):79-87. PubMed ID: 213379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoblastoid cell lines, transformed by Epstein-Barr virus, in the enzymatic study of hereditary lysosomal storage diseases.
    Watanabe Y; Minami R
    Tohoku J Exp Med; 1981 Jul; 134(3):229-43. PubMed ID: 6274059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tandem mass spectrometry triplex assay for the detection of Fabry, Pompe, and mucopolysaccharidosis-I (Hurler).
    Duffey TA; Bellamy G; Elliott S; Fox AC; Glass M; Turecek F; Gelb MH; Scott CR
    Clin Chem; 2010 Dec; 56(12):1854-61. PubMed ID: 20940330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry.
    Elliott S; Buroker N; Cournoyer JJ; Potier AM; Trometer JD; Elbin C; Schermer MJ; Kantola J; Boyce A; Turecek F; Gelb MH; Scott CR
    Mol Genet Metab; 2016 Aug; 118(4):304-9. PubMed ID: 27238910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External quality assurance programme for enzymatic analysis of lysosomal storage diseases: a pilot study.
    Ruijter GJ; Boer M; Weykamp CW; de Vries R; van den Berg I; Janssens-Puister J; Niezen-Koning K; Wevers RA; Poorthuis BJ; van Diggelen OP
    J Inherit Metab Dis; 2005; 28(6):979-90. PubMed ID: 16435191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria.
    Mechtler TP; Stary S; Metz TF; De Jesús VR; Greber-Platzer S; Pollak A; Herkner KR; Streubel B; Kasper DC
    Lancet; 2012 Jan; 379(9813):335-41. PubMed ID: 22133539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal storage disorder 4+1 multiplex assay for newborn screening using tandem mass spectrometry: application to a small-scale population study for five lysosomal storage disorders.
    Orsini JJ; Martin MM; Showers AL; Bodamer OA; Zhang XK; Gelb MH; Caggana M
    Clin Chim Acta; 2012 Aug; 413(15-16):1270-3. PubMed ID: 22548856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A column-switching HPLC-MS/MS method for mucopolysaccharidosis type I analysis in a multiplex assay for the simultaneous newborn screening of six lysosomal storage disorders.
    Gucciardi A; Legnini E; Di Gangi IM; Corbetta C; Tomanin R; Scarpa M; Giordano G
    Biomed Chromatogr; 2014 Aug; 28(8):1131-9. PubMed ID: 24449175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry.
    Scott CR; Elliott S; Buroker N; Thomas LI; Keutzer J; Glass M; Gelb MH; Turecek F
    J Pediatr; 2013 Aug; 163(2):498-503. PubMed ID: 23465405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease.
    Suzuki Y
    Brain Dev; 2013 Jun; 35(6):515-23. PubMed ID: 23290321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of variant lysosomal acid glycosidases of Anderson-Fabry and Pompe disease in a human embryonic kidney epithelial cell line (HEK 293 T).
    Ebrahim HY; Baker RJ; Mehta AB; Hughes DA
    J Inherit Metab Dis; 2012 Mar; 35(2):325-34. PubMed ID: 21972175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Glucosidase isoenzymes in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with type 1 Gaucher disease.
    Maret A; Salvayre R; Samadi M; Douste-Blazy L
    Enzyme; 1987; 37(4):208-17. PubMed ID: 3038513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri.
    Hopkins PV; Campbell C; Klug T; Rogers S; Raburn-Miller J; Kiesling J
    J Pediatr; 2015 Jan; 166(1):172-7. PubMed ID: 25444528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment prospects of lysosomal storage disorders].
    Reismann P; Tulassay Z
    Orv Hetil; 2008 Jun; 149(25):1171-9. PubMed ID: 18547894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.